Inventor
MOGI MUNETO
US32 patents
⚠️ This page may combine multiple inventors who share the name “MOGI MUNETO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
7 patentsUS8377978B2Feb 19, 2013
Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
NOVARTIS AG5 citations83
US10537563B2Jan 21, 2020
Methods for treating ocular disease using inhibitors of CSF-1R
NOVARTIS AG2 citations70
US11478480B2Oct 25, 2022
Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
NOVARTIS AG4 citations66
US11234982B2Feb 1, 2022
Methods for treating ocular surface pain
NOVARTIS AG0 citations56
US10550102B2Feb 4, 2020
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
NOVARTIS AG0 citations49
US9603819B2Mar 28, 2017
Substituted aminobutyric derivatives as neprilysin inhibitors
NOVARTIS AG0 citations49
US12129246B1Oct 29, 2024
Hydroquinazoline derivatives for the treatment of a disease or disorder
NOVARTIS AG0 citations45
XENTION LTD
4 patentsUS7615557B2Nov 10, 2009
Tetrahydro-naphthalene and urea derivatives
XENTION LTD9 citations81
US7381840B2Jun 3, 2008
Tetrahydro-naphthalene derivatives
XENTION LTD7 citations72
US7612113B2Nov 3, 2009
Hydroxy tetrahydro-naphthalenylurea derivatives
XENTION LTD6 citations61
US7544716B2Jun 9, 2009
Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
XENTION LTD6 citations61
MOGI MUNETO
4 patentsUS8440682B2May 14, 2013
4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
MOGI MUNETO0 citations48
US8420641B2Apr 16, 2013
Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives
MOGI MUNETO0 citations48
US8193349B2Jun 5, 2012
4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
MOGI MUNETO0 citations48
US8759365B2Jun 24, 2014
Organic compounds
MOGI MUNETO0 citations39
COPPOLA GARY MARK
3 patentsUS8263629B2Sep 11, 2012
Substituted aminobutyric derivatives as neprilysin inhibitors
COPPOLA GARY MARK21 citations91
US8394853B2Mar 12, 2013
Substituted aminopropionic derivatives as neprilysin inhibitors
COPPOLA GARY MARK12 citations82
US9006249B2Apr 14, 2015
Substituted aminobutyric derivatives as neprilysin inhibitors
COPPOLA GARY MARK3 citations61
ADAMS CHRISTOPHER M
3 patentsUS10208018B2Feb 19, 2019
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations48
US9765067B2Sep 19, 2017
Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations38
US9957254B2May 1, 2018
Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
ADAMS CHRISTOPHER M0 citations36